Title : Use of the Prostacyclin Receptor Agonist Selexipag in Patients With Pulmonary Arterial Hypertension Associated With Eisenmenger Syndrome.

Pub. Date : 2021 Aug

PMID : 33539988






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Use of the Prostacyclin-Receptor Agonist Selexipag in Pulmonary Arterial Hypertension Associated with Eisenmenger Syndrome. selexipag prostaglandin I2 receptor Homo sapiens
2 We present three patients with Eisenmenger syndrome and their improvement after initiation of Selexipag, an oral selective IP prostacyclin-receptor agonist. selexipag prostaglandin I2 receptor Homo sapiens